Webinar | The new Medical Devices Regulation - An engine for EDC substitution?
Endocrine disrupting chemicals (EDCs) are a group of chemicals that interfere with hormones and the endocrine system. Bisphenol A (BPA) and phthalates are known EDCs commonly found in medical devices. There have been documented cases of EDCs leaching from PVC devices like blood bags, medical gloves and intravenous tubing. We know that exposure to EDCs has been associated with an increase in the incidence of hormone-related diseases and illnesses.
In the 7th Environmental Action Programme (7th EAP) the EU committed to develop horizontal measures to ensure the minimisation of exposure to EDCs by 2015. There was also a political commitment in the 7th EAP to develop horizontal EDC criteria applicable to all current and future laws.
The new Medical Devices Regulation addresses the presence of Carcinogenic, Mutagenic and Reprotoxic substances (CMRs) and Endocrine Disrupting Chemicals (EDCs) contained in such devices. This Webinar explores how these new rules will work in practice. We discuss examples of substitutions that already exist both on the side of procurement and on the supply side. This should provide practical guidance to the EU member states and encourage them meet the objectives of REACH: making sure that in the future toxic substances are indeed replaced by safer alternatives.